CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that due to an unforeseen scheduling issue with its guest speaker, the first program in the company’s series of RNAi Roundtable webcasts has been rescheduled. “ALN-CC5 for the Treatment of Complement-Mediated Diseases,” which was originally scheduled for Friday, July 17, 8:00 – 9:00 a.m. ET will now take place Thursday, July 23, 9:00 – 10:00 a.m. ET. Revised details of the program are listed below. There are no additional changes at this time to any of the other Roundtable webcasts which were previously announced.
Help employers find you! Check out all the jobs and post your resume.
